IR 05000232/2014001: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Adams
{{Adams
| number = ML20148Q722
| number = ML22095A285
| issue date = 06/27/1997
| issue date = 04/05/2022
| title = Amend 10 to License 50-23214-01 for Healthsouth Diagnostic Ctrs,Authorizing Transport of Licensed Matls Only IAW Provisions of 10CFR71
| title = 627275-Amendment 24 License 50-23214-01/030-20372 for Diagnostic Health Center of Anchorage, LLC
| author name = Prange B
| author name = Hanson L
| author affiliation = NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION IV)
| author affiliation = NRC/RGN-IV/DNMS
| addressee name =  
| addressee name =  
| addressee affiliation =  
| addressee affiliation = NRC/Document Control Desk
| docket = 03020372
| docket = 03020372
| license number = 50-23214-01-A10
| license number = 50-23214-01
| contact person =  
| contact person =  
| document report number = 50-23214-01, 572487, NUDOCS 9707070195
| case reference number = License-627275-165144
| document type = DKT 30 MTL BYPRODUCT, LICENSE,MTL/BYPRODUCT & AMEND TO LICENSE (DKT 30), TEXT-LICENSE APPLICATIONS & PERMITS
| document type = License-Approval for MATL Byproduct License (Amend/Renewal/New) DKT 30, 40, 70
| page count = 18
| page count = 1
}}
}}


Line 18: Line 18:


=Text=
=Text=
{{#Wiki_filter:*
{{#Wiki_filter:NRC FORM 374         PAGE 1 OF 3 PAGES U.S. NUCLEAR REGULATORY COMMISSION   Amendment No. 24 MATERIALS LICENSE Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s)
  .
and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified belo Licensee  In accordance with letter dated  4. Expiration Date: March 31, 2025 July 6, 2021 1. Diagnostic Health Center of Anchorage, LLC A wholly owned subsidiary of Alliance HealthCare Services 5. Docket No.: 030-20372 2. 4100 Lake Otis Parkway #102  3. License No.: 50-23214-01 is  Reference No.:
p w w wm wisz w w w w w w wm m w m m w w w w Innaaanat mm anal mm lacw w w.m m w w w w w w 12 w FORM 374   U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE   g (8 ,
Anchorage, AK 99508    amended in its entirety to read as follows: Byproduct, source, Chemical and/or physical form Maximum amount that licensee Authorized use and/or special nuclear    may possess at any one time material      under this license Any byproduct material Any As Needed For use in uptake, dilution and permitted by 10 CFR        excretion studies permitted by 10 CFR 35.100        35.10 Any byproduct material Any As Needed For use in imaging and localization permitted by 10 CFR        studies permitted by 10 CFR 35.20 .200 Iodine-131 Any millicuries total Any sodium iodide Iodine-131 use permitted by 10 CFR 35.300 for which the patient can be released under the provisions of 10 CFR 35.7 Any byproduct material Prepackaged Kits millicuries total For use in in-vitro studie permitted by 10 CFR 31.11
3 ,
3 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public   g L g
- Federal Regulations, Chapter I, Parts 30,31,32,33,34,35,36,39,40, and 70, and in reliance on statements and representations heretofore m by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer b material designated below; to use such material for the purpose (s) and at the place (s) designated below; to deliver or transfer such material to f
*
persons authorized to receive it in accordance with the regulations of the applicable Part(s).This license shall be deeme specified in section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and order
*          Rj Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below.


El
NRC FORM 374A    U.S. NUCLEAR REGULATORY COMMISSION  PAGE 2 OF 3 PAGES License No.: 50-23214-01 Docket or Reference No.:
  $.         5 31          D C
MATERIALS LICENSE    030-20372 SUPPLEMENTARY SHEET Amendment No. 24 CONDITIONS 10. Licensed material may be used only at the licensees facilities located at Lake Otis Medical Plaza, 4100 Lake Otis Parkway #102, Anchorage, Alaska.
  '
In accordance with letter dated l 3. L e e N th r    E'
N 1.


a Healthsouth Diagnostic Centers    50-23214-01 is amended in  gl j of Anchorage, LTD. its entirety to read as follows:  g'
11. The Radiation Safety Officer for this license is Kay Kassel, MS, CNMT.
2. 4003 Lake Otis Parkway, #101 l Ancnorage, Alaska 99508
      . 4. Expiration Date Rantomhpr 'An; 2004  g y
5. Docket or    y'
J 3 #    Reference No. 030-20372  g g
7. Chemical and/or Physical  8. Maximum Amount that Licensee g y 6. Byproduct, Source, and/or Form  May Possess at Any One Time g a Special Nuclear Material Under This License j          g E
i s A. Any byproduct .
A. Any  A. As needed  E
$ material identified  radiopharmaceutical    E
# in 10 CFR 35.100  identified in    E E
,s    10 CFR .35.100  ..
B. Any byproduct  B. Any  B. As needed  g E    .
i material identified  " radiopharmaceutical . g
; in 10 CFR 35.200 .  . identified in    s
,
j  i,
  ' ,
10 CFR.35.200    j s C. Iodine-131  C. Iodide'  C. 30 millicuries per E s        dose; not to exceed E 5        70 millicuries  E
!        total  E n


j D. Strontium-89  D. Chloride .
12. Licensed material shall only be used by, or under the supervision of:
      '
A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.1 B. The following individuals are authorized users for the material and medical uses as indicated:
D. 4 millicuries per j l
Authorized Users  Material and Use Marc R. Beck, .100; 35.200; Oral administration of sodium iodide I-131; 31.11 Robert L. Bridges, .100; 35.200; Oral administration of sodium iodide I-131; 31.11 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for establishing decommissioning financial assuranc NRC FORM 374A   U.S. NUCLEAR REGULATORY COMMISSION   PAGE 3 OF 3 PAGES License No.: 50-23214-01  Docket or Reference No.:
    '
MATERIALS LICENSE     030-20372 SUPPLEMENTARY SHEET Amendment No. 24 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations. Additionally, this license condition does not limit the licensees ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commissions regulations shall govern unless the statements, representations, and procedures in the licensees application and correspondence are more restrictive than the regulation A. Application dated October 20, 2014 (ML14336A723)
    .
B. Letter dated February 16, 2015 with enclosures (ML15061A178)
    '-
C. Letter dated July 6, 2021 (ML21196A052)
      ~ ~
FOR THE U.S. NUCLEAR REGULATORY COMMISSION Digitally signed by Latischa Latischa M. Hanson Hanson April 5, 2022      Date: 2022.04.05 19:20:39 -05'00'
dose; not to exceed g q
Date:     By:
[
Latischa M. Hanson Region IV ML22073A267
a 8 millicuries total j E
 
*          E j 9. Authorized use        g W
          ,
          ' '
5; A. Medical use described in 10 CFR 35.100.
 
"
B. Medical use described in 10 CFR 35.200.      !
          "
C. Diagnosis and treatment of hyperthyroidism and cardiac dysfunction.
 
l-g D. Treatment of pain due to metastatic bone carcinoma.      l
=          n e
 
e
 
=
140042      a
        ~
          '
g 1A h      {
(
u l(3 O
_
  /h  g
_ _ _ _ _ _ _ w _ _ w  _ _m__m_  a
 
E pxm ulww w www w w wwU.S.
 
NRC FORM 374A ww w w w w ww w ww w w w w auncwwPAGE NUCLEAR REGULATORY COMMISSloN w wjw w OF w == =gww PAGESw wgl
  '
    ''''"" "Tf-23 214-01 g!
M .      $l n ,
y  MATERIALS LICENSE  oocteior ggeggr  Ej j  SUPPLEMENTARY SHEET    Ei l N    Amendment No. 10 *l l Ei W
E N        '
E (-      E s
E W    CONDITIONS E
W ( 10. Licensed material shall be used only at the licensee's facilities located at  E B 4003 Lake Otis Parkway, #101, Anchorage, Alaska. E 4 g      E 3 11. The Radiation Safety Officer for this license is John J. McCormick, M.D. W E!
 
s 12. Licensed material listed in Item 6 above is only authorized for use by, or_ under the E 3 supervision of, the following individuals for the materials and uses indicated: E E
 
y Authorized Users  Material and Use   E I
s a      E j Harold F. Cable, M.D. 10 CFR 35.100, 35.200 and Iodine-131 E a      E j George H. Ladyman, M.D. 10 CFR 35.100, 35.200, Iodine-131,  E y    and Strontium-89  E
*      E
,
j' James L. Faries, M.D. 10 CFR 35.100, 35.200, Iodine-131,  E ,
g    and Strontium-89  g E
d    10 CFR 35.100, 35.200 and Iodine-131 John J. McCormick, M.D. g ,
        '
E E
'
13. The licensee is authorized to transport licensed material only in accordance with a the provisions of 10 CFR Part 71, " Packaging and Transportation of Radioactive i Material."      j E
,      E 3      E )
 
,-
E l
,
4      E ;
p
,
a..
,
E
-
E d
-
E!
        -
3      e
*
,-
Wii p
W      E l E
$
#
E
 
liii
 
4
-
E !
-
E ,
M      Eil
$      II!
-
M      Ell
=        l1
 
  -
  .
'
  - w ww mmm w w w ww2 m w w w m w w m m ww ww wm m mmm w w w wanci  ,
FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE OF PAGES .
  *
-
N y  .
    '"'"* NT523214-01  E E
f,,
y  MATERIALS LICENSE ooctei= g pyg37pr  ( l;l '
g  SUPPLEMENTARY SHEET     E ,
N    Amendment No. 10 E !
'
I W        E E i N
N        E l 5        E I N -
E i Except as specifically provided otherwise in this license, the licensee shall
'
A 14.      E N conduct its program in accordance with the statements, representations, and E I'
N procedures contained in the documents, including any enclosures, listed below,-  E N except for minor changes in the medical use radiation safety procedures as provided E N in 10 CFR 35.31. The Nuclear Regulatory Commission's regulations shall govern E,
. s unless the statements, representations, and procedures in the licensee's application E R and correspondence are more restrictive than the regulations. E R        E
, s , A. Letter dated July 29, 1994    W
; 3 -B. Letter dated August 11, 1994    E
$ C. Application dated August 1, 1994    E y D. Letter dated August 15, 1994    E 3 E. Letter dated April 8, 1997    E
>
g F. Letter received May 15, 1997    E y G. Letter dated May 21, 1997    E W        E N        E N        E
!        E B        E s        E s        E l R        E
'        !
N        E s        E N        E W        si s        E I
W        E W        'E
        '
R .
E 8        E k        E
$        $
5        E FOR THE U.S. NUCLEAR REGULATORY COMMISSION 4        E
!!        E
$
Date    By '8sDZfM  E N
MaterialsBrancg  ,
Region IV, WCF0  El Walnut Creek, California 94596 m        E 4        E 4        E ;
9        E l 5        E ,
#
.        $i I
 
.
*
.
  ;jpg(o 6  . FOR trR5 USE)
( BEftbN:  ! -s W ticensereeynage;nenterancs. ARM l Pro ram Cg;  O pg Seetonal Licensing Sections  - bedategory: 7C
    .  , ,.,
i::P&ll'Afff"j% e"*"".'!".^"r:.imi:::::,: .:.r.;7 m 17 ra 12: 11 8 LICE 05E FEE TRANSMITTAL A. REGl0N $ [hfD Udd$!!$1E' 08? SAGE DIAGNOSUC IMMIM CM.
 
Eo'ni%"R4.:  fili}''
Nt$onT !  t 2. gu ^
  '
y Check No. ,1 i 3. COMMENTS U  g M
  !!!"'d
    '
v-/ 4-37 B. LICENSE FEE MANAGEMENT BRANCH pckwhenmilestone03is ter d / )
1. fee Category and Amount-  ,
2. ge se Paid. plication may be processed for:
fi":":e si Dalned e siirs w /
k
    [''U (/
A - .
e Log-____ll5__&__[__lAf_Q_(p  )
Remitter . _ _ _ _ _ _ _ _ _ _ , , ,
Check No.. _  ____
____
AmCategory Fee o unt_._- _ _._ Yh____ ___
Type of F ________  __ __
        -
Date C a Rec'd.
 
l    Data ( p e d. / _ _ ,,'_ [
l    av: ,________________________
l (
,
f
 
    ,  .
  '
.
  .j.      l
        '
UNITED STATES h-
-
I
[o  NUCLEAR REGULATORY COMMISSION
 
==REGION IV==
.
 
.o
  {
s
*
.b*y,p NV jf  Walnut Creek Field Office 1450 Maria Lane .  ,
    ' Walnut Creek, California 94596-5368,  l
    ' JUN 2 7 1997 -
Healthsouth' Diagnostic Centers .
of Anchorage, LTD.
 
-ATTN: John J. McCormick Radiation Safety Officer 4003 Lake Otis Parkway, #101 Anchorage, Alaska 99508      '
.
SUBJECT: ' LICENSE AMENDMENT AND NOTICE OF VIOLATION
.
Please find enclosed License No. 50-23214-01. You should review this license carefully
^ gnd be sure that you understand all conditions.
 
Please note that as part of this amendment, in accordance with 10 CFR 30.36, effective February 15,1996, the expiration date of your license has been extended by a period of five years. Your new expiration date is stated in item 4 of the license. If you have any questions,'you may contact the reviewer who signed your license at (510) 975 0250.
 
.
NRC expects licensees to conduct their programs with meticulous attention to detail and a
 
high standard of compliance. Because of the serious consequences to employees and the public which can result from failure to comply with NRC requirements, you must conduct your program involving radioactive materials in accordance with the conditions of your NRC license, representations made in your license application, and NRC regulations. In particular, note that you must:
1. Operate in accordance with NRC regulations 10 CFR Part 19, " Notices, Instructions and Reports to Workers: Inspection and investigations," 10 CFR Part 20,
  " Standards for Protection Against Radiation," and other applicable regulations.
 
2. Possess radioactive material only in the quantity and form indicated in your license.
 
3. Use radioactive material only for the purpose (s) indicated in your license.
 
4. Notify NRC in writing of any change in mailing address (no fee required if the location of radioactive material remains the same).
 
5. Request and obtain written NRC consent before transferring your license or any right thereunder, either voluntarily or involuntarily, directly or indirectly, through transfer of control of your license to any person or entity. A transfer of control of your license includes not only a total change of ownership, but also a change in the controlling interest in your company whether it is a corporation, partnership, or other entity, in addition, appropriate license amendments must be requested and obtained for any other planned changes in your facility or program that are centrary to your license or contrary to representations made in your license application, as
 
  .-  _  - --
*
.
*
;
'
Heathsouth Diagnostic Centers  -2-of Anchorage, LTD.
 
well as supplemental correspondence thereto, which are incorporated into your license. A license fee may be charged for the amendments if you are not in a fee-exempt category.
 
6. Maintain in a single document, decommissioning records that have been certified for completeness and accuracy listing all the following items applicable to the license:
  * Onsite areas designated or formerly designated as restricted areas as defined in 10 CFR 20.3(a)(14) or 20.1003.
 
* Onsite areas, other than restricted areas, where radioactive materials in quantities greater than amounts listed in Appendix C to 10 CFR
, 7  20.1001 20.2401 have been used, possessed, or stored.
 
'
  * Onsite areas, other than restricted areas, where spills or other unusual occurrences involving the spread of contamination in and around the facility, equipment, or site have occurred that required reporting pursuant to 10 CFR 30.50(b)(1) or (b)(4), including areas where subsequent cleanup procedures have removed the contamination.
 
* Specific locations and radionuclide contents of previous and current burial areas within the site, excluding radioactive material with half-lives of 10 days or less, depleted uranium used only for shielding or as penetrators in unused munitions, or sealed sources authorized for use at temporary job sites.
 
* Location and description of all contaminated equipment involved in licensed )
4  operations that is to remain onsite after license termination.
 
7. Submit a complete renewal application with proper fee, or termination request at i least 30 days before the expiration date on your license. You will receive a reminder notice approximately 90 days before the expiration date. Possession of ;
radioactive material after your license expires is a violation of NRC regulations. l 8. Request termination of your license if you plan to permanently discontinue activities involving radioactive material.
 
You will be periodically inspected by NRC. Failure to conduct your program in accordance I
        '
with NRC regulations, license conditions, and representations made in your license application and suppic. mental correspondence with NRC will result in enforcement action l against you. This could include issuance of a notice of violation; imposition of a civil l
penalty; or an order suspending, modifying, or revoking your license as specified in the
" General Statement of Policy and Procedure for NRC Enforcement Actions" (Enforcement Policy), 60 FR 34381, June 30,1995.
 
*
l I
 
*
.
.
Heathsouth Diagnostic Centers  -3-of Anchorage, LTD.
 
This letter also responds to your letter dated' April 8,1997, to your letter received May 15,1997, and to your letter dated May 21,1997, wherein the NRC was informed of ~
the direct transfer of License 50-23214-01, effective February 3,1997. We find that the -
information supplied by Healthsouth Diagnostic Centers of Anchorage, LTD. was sufficient to make a finding that the transfer was in accordance with the Atomic Energy Act of 1954, as amended. However, the license transfer should not have _taken place until the NRC had given its written consent, as required by 10 CFR 30.34(b).
 
Therefore, enclosed with this letter is a Notice of Violation (Notice) based ~on failure to !
      '
obtain prior written consent from NRC to this license transfer. Your actions in response to this matter were considered appropriate and we are nol requiring you to resoond to the
: Notice.
 
Should you have any questions regarding this matter, feel free to contact Beth Prange of my staff at 510-975-0250.
 
Sincerely,
'
Frank A. Wenslawski, Chief Materials Branch Docket: 030-20372 License: 50-23214-01 Control: 572487
.
 
===Enclosures:===
As stated
 
REGION IV==
kt    Walnut Creek Field Office 4,,,,,  1450 Maria Lane Walnut Creek, Califomia 94596-5368
,
;    'APR 16 g Anchorage Diagnostic Imaging Center, Inc.
 
l  ATTN: Kay Ladyman
!-  Administrator
'
4003 Lake Otis Parkway, Suite 101 Anchorage, Alaska 99508-5211
.
SUBJECT: ACKNOWLEDGMENT OF REQUEST FOR LICENSING ACTION
,        .
REFERENCE: Letter dated April 8,1997
        .
,
DWe have completed the administrative review and initial processing of your application.
:  ' During the initial processing, some deficiencies were identified. Please provide us with answers to the questions in Attachment 1 to NRC Information Notice 89-25, Rev.1 (copy  ;
,
enclosed). This information should be provided within 30 days from the date of this letter, so that your request can be forwarded for technical review. Please note that the technical l  review may identify additional omissions in the submitted information or technical issues .
j'
-  that require additional information. l
 
Amendment actions are normally processed within 90 days, unless the technical review L  identifies:
  * Major technical deficiencies
  * Policy issues that require input and coordination with other NRC Regional offices, 1  Agreement State offices, or NRC's Office of Nuclear Materials and Safeguards A ccpy of your correspondence has been forwarded to our License Fee and Accounts
'  Receivable Branch, Office of the Controller, who will contact yau separately if the  !
l  appropriate license fee has not been submitted for your request, or for billing if your request is subject to full cost recovery.
 
I  Any correspondence about this application should reference the Control number listed below.
 
.   
 
Sincerely,
.
:    W G,  M* 4
,
Beth :    Sr. Health Physicist (Licensing)
Materials Branch
'
Docket No.- 030-20372 License No. 50 23214-01
*~
Control No. 572487 Enclosure: As stated
  .. . _  - -. . .
 
  , - _. . -.  . . -
.,' -
  ....
, .,
'A
 
l Anchorage Diagnostic  -2-Imaging Center, Inc.
 
, bec:
, Docket File J
;
4 .
;
e
,
 
G:\572487.aki To receive a copy of this document, indicate in the box "C" - Copy withcut
<
attachment / enclosure ."E" - Copy with attachment / enclosure "N" - No Copy OFFICE RIV:WCFO:NMLB !N  N NAME  J. Garcia ' h [
DATE f/k/97 hh
  '
y//[f 97 v
,
 
DArg' ' 7 ~j  9
  . u.s. cuchuAs ascutAtoav coxmIssIow
.
RfCION V    5/,g/gr7 TIME  :
TELEPHONE'OR VERBAL CONVERSATION
  -
RECORD  ,
  '
'
  [ ] INCOMING CALL.  [rf OUTGOING CALL  [ ] VISIT -  l IIRSON CALLING 3  OFFICE /ALDRESS:  PHONE WlHB D hn&gn3  "  *  raoxt MtusrR:
        ~
frnSow cA1,Lto:  orrIcs/AconEsS:  ,
k fY' , CMmT' S*    ,Y.
 
'
90 7 -563- 3V 9.1 CONVERS5 TION
        ~
D h /v@ Gkg, btc . Cu%sh , "
__
        ._
SUFD(ARY -
        '
  ~ CsYe.A  tk 'LL ~
Wlfl9 ] O C~W ~>'Nh  bf 7-
// c a w / a a s 4    a yL 'y ;p ,
.
##, - - % ~ % ..      .
l
          .
l I
l
          !
        -
, REFERRED TO:      ( ) ADVISE KI 03 ACTICI I
TAIII
  ~~  ~
,ACTIOI REQUISTEDI    IIITIA10:  !
-
I l      DATE:
I
) ACT103 TAKIBIt    111TIALS:
CATI:
!  ~-  ~~-~~~--~    "
j yac- roin 2 a nuv-o a /o3 1EF7QUmTiF-
. . _ . _ _ _____. _ _ _ __ _._ _ . _ . _ _ . _ _ _ _ . . _ _ . _ _ _ _ _
 
  . _  . .
'
'
      [ll&LhfA$lV
*
      $dh24?22 HEALTHSOUTH,
 
we~9 7,_y}
      , f',
W O{
      '
rn .
jmi
*
HEALTHSOUTH DIAGNOSTIC CENTERS OF ANCHORAGE, LTD.
 
4003 LAKE OTIS PARKWAY SUITE 101 k{ [, f J
ANCHORAGE, ALASKA 99508-5211  y,g j( gb_,4y(
  (Formerly Anchorage Diagnostic Imaging Center. Inc.) t !T*
W:.% ,
      , fn April 8, 1997    ( __21
,
U. S. Nuclear Regulatory Commission Region IV Nuclear Material Safety Section 61' Ryan Plaza Drive, Suite 400 Arlington, Texas 76011-8064 RE: Radioactive Materials License #50-23214-01/ Anchorage Diagnostic Imaging Center, Inc. NAME AND OWNERSHIP CHANGE.
 
To whom it may concern:
The purpose of this amendment is to change the facility name and ownership of the site listed on this Radioactive Materials License.
 
We request that the name for this license be changed to HEALTHSOUTH DIAGNOSTIC CENTERS OF ANCHORAGE, LTD. The new owner is Healthsouth Diagnostic Centers, 1 Healthsouth Parkway, Birmingham, AL 35243. The current location of use, 4003 Lake Otis Parkway, Suite 101, Anchorage, AK, remains the same.
 
In_ addition, please remov_e, Ronald O. Shriver, M.D. as an authorized user on the license.
 
All other items concerning this byproduct materials license remains unchanged at this time. Pleace contact Tom Scott, CNMT, or Jeff Kirk, BSRT, CNMT at (907)S63--3493 if additional information is required. I thank you in advance for your prompt attention regarding this matter.
 
Respectfully,
  ''
(/
 
M m Kay adyman      ,
Administrator kl      I I
. Enclosure: Anchorage Diagnostic Imaging Center Check #4174 in the  i amount of $440.00    l
        !
l 522 C  l
-
}}
}}

Latest revision as of 02:43, 11 May 2022

627275-Amendment 24 License 50-23214-01/030-20372 for Diagnostic Health Center of Anchorage, LLC
ML22095A285
Person / Time
Site: 05000232, 03020372
Issue date: 04/05/2022
From: Latischa Hanson
Division of Nuclear Materials Safety IV
To:
Document Control Desk
References
License-627275-165144
Download: ML22095A285 (1)
v • d • e


Text

NRC FORM 374 PAGE 1 OF 3 PAGES U.S. NUCLEAR REGULATORY COMMISSION Amendment No. 24 MATERIALS LICENSE Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s)

and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified belo Licensee In accordance with letter dated 4. Expiration Date: March 31, 2025 July 6, 2021 1. Diagnostic Health Center of Anchorage, LLC A wholly owned subsidiary of Alliance HealthCare Services 5. Docket No.: 030-20372 2. 4100 Lake Otis Parkway #102 3. License No.: 50-23214-01 is Reference No.:

Anchorage, AK 99508 amended in its entirety to read as follows: Byproduct, source, Chemical and/or physical form Maximum amount that licensee Authorized use and/or special nuclear may possess at any one time material under this license Any byproduct material Any As Needed For use in uptake, dilution and permitted by 10 CFR excretion studies permitted by 10 CFR 35.100 35.10 Any byproduct material Any As Needed For use in imaging and localization permitted by 10 CFR studies permitted by 10 CFR 35.20 .200 Iodine-131 Any millicuries total Any sodium iodide Iodine-131 use permitted by 10 CFR 35.300 for which the patient can be released under the provisions of 10 CFR 35.7 Any byproduct material Prepackaged Kits millicuries total For use in in-vitro studie permitted by 10 CFR 31.11

NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 3 PAGES License No.: 50-23214-01 Docket or Reference No.:

MATERIALS LICENSE 030-20372 SUPPLEMENTARY SHEET Amendment No. 24 CONDITIONS 10. Licensed material may be used only at the licensees facilities located at Lake Otis Medical Plaza, 4100 Lake Otis Parkway #102, Anchorage, Alaska.

11. The Radiation Safety Officer for this license is Kay Kassel, MS, CNMT.

12. Licensed material shall only be used by, or under the supervision of:

A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.1 B. The following individuals are authorized users for the material and medical uses as indicated:

Authorized Users Material and Use Marc R. Beck, .100; 35.200; Oral administration of sodium iodide I-131; 31.11 Robert L. Bridges, .100; 35.200; Oral administration of sodium iodide I-131; 31.11 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for establishing decommissioning financial assuranc NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES License No.: 50-23214-01 Docket or Reference No.:

MATERIALS LICENSE 030-20372 SUPPLEMENTARY SHEET Amendment No. 24 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations. Additionally, this license condition does not limit the licensees ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commissions regulations shall govern unless the statements, representations, and procedures in the licensees application and correspondence are more restrictive than the regulation A. Application dated October 20, 2014 (ML14336A723)

B. Letter dated February 16, 2015 with enclosures (ML15061A178)

C. Letter dated July 6, 2021 (ML21196A052)

FOR THE U.S. NUCLEAR REGULATORY COMMISSION Digitally signed by Latischa Latischa M. Hanson Hanson April 5, 2022 Date: 2022.04.05 19:20:39 -05'00'

Date: By:

Latischa M. Hanson Region IV ML22073A267

Retrieved from "https://kanterella.com/w/index.php?title=IR_05000232/2014001&oldid=3441922"